Home
Live Updates
Krystal Biotech, Inc.: Krystal Biotech Announces First Quarter 2023 Financial Results and Operational Highlights : comparemela.com
Krystal Biotech, Inc.: Krystal Biotech Announces First Quarter 2023 Financial Results and Operational Highlights
PDUFA date of May 19, 2023Presented clinical data at ARVO on topical application of B-VEC to the eye to treat ocular complications in a patient with recessive dystrophic epidermolysis bullosa under Compassionate
Related Keywords
Pennsylvania ,
United States ,
Japan ,
Australia ,
Krishs Krishnan ,
,
Nasdaq ,
Company Biologics License Application ,
Jeune Aesthetics Inc ,
Us Food Drug Administration ,
Exchange Commission ,
Twitter ,
Ministry Of Health ,
Linkedin ,
Krystal Biotech Inc ,
Association For Research ,
Compassionate Use Program ,
European Medicines Agency ,
Compassionate Use ,
Dystrophic Epidermolysis Bullosa ,
Drug Administration ,
Prescription Drug User Fee Act ,
Biologics License Application ,
Pediatric Investigation Plan ,
Marketing Authorization Application ,
Cartagena Act ,
Therapeutics Development Network ,
Cystic Fibrosis Foundation ,
Jeune Aesthetics ,
Krystal Biotech ,
Private Securities Litigation Reform Act ,
Balance Sheet Data ,
Gefallene Big Techs ,
Krystal ,
Biotech ,
Nnounces ,
First ,
Quarter ,
023 ,
Financial ,
Results ,
Perational ,
Highlights ,
comparemela.com © 2020. All Rights Reserved.